HRT Financial’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,276
Closed -$11K 5457
2026
Q1
$11K Buy
+11,276
New +$19.1K ﹤0.01% 3631
2025
Q3
Sell
-9,148
Closed -$42K 3751
2025
Q2
$42K Buy
+9,148
New +$49.5K ﹤0.01% 2328
2024
Q4
Sell
-1,046
Closed -$7K 3325
2024
Q3
$7K Buy
+1,046
New +$33.6K ﹤0.01% 2252
2022
Q4
Sell
-15
Closed -$16K 3225
2022
Q3
$16K Buy
+15
New +$28.5K ﹤0.01% 2503

Other funds holding VTAK

HRT Financial's VTAK Position: Q2 2026 in Review

HRT Financial sold out of Catheter Precision (VTAK) in Q2 2026, closing a stake of 11,276 shares — an estimated $11K sold.

HRT Financial first reported a position in VTAK in Q3 2022 and held it in 4 quarters. The position peaked at $42K in Q2 2025. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.

  • HRT Financial reported no remaining Catheter Precision position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 11,276 Catheter Precision shares in Q2 2026, an estimated $11K.
  • HRT Financial first reported a position in Catheter Precision in Q3 2022 and held it in 4 quarters.
  • HRT Financial's Catheter Precision position peaked at $42K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.